While increased CPT1A expression in ER+ breast cancer patients was associated with a significant decrease in overall survival, no data are available on obesity and other metabolic health parameters in this patient population. This evidence concerns the gene CPT1A and obesity due to melanocortin 4 receptor deficiency.